Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub‐cohort analysis of a phase <scp>III</scp> , randomized, double‐blind, placebo‐controlled trial-Reference-Cited by-全球学者库

Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub‐cohort analysis of a phase III , randomized, double‐blind, placebo‐controlled trial

Published:2022-02 Issue:2 Volume:23 Page:99-110
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:J of Digest Diseases

Author:

Peng Li Hua¹,Fang Jing Yuan²,Dai Ning³,Shen Xi Zhong⁴,Yang You Lin⁵,Sun Jing⁶,Yang Yun Sheng¹

Affiliation:

1. Department of Gastroenterology and Hepatology, The First Medical Center Chinese PLA General Hospital Beijing China

2. State Key Laboratory for Oncogenes and Related Genes, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology Shanghai Cancer Institute, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai China

3. Department of Gastroenterology, Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang Province China

4. Department of Gastroenterology Zhongshan Hospital, Fudan University Shanghai China

5. Department of Gastroenterology The First Affiliated Hospital of Harbin Medical University Harbin Heilongjiang Province China

6. Department of Gastroenterology Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China

Funder

AstraZeneca Pharma Poland

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.13081

Reference32 articles.

1. Irritable bowel syndrome;Enck P;Nat Rev Dis Primers.,2016

2. Bowel disorders;Mearin F;Gastroenterology.,2016

3. Chronic constipation: new insights, better outcomes?;Schiller LR;Lancet Gastroenterol Hepatol.,2019

4. Study Group of Functional Gastrointestinal Disorders, Study Group of Gastrointestinal Motility, Chinese Society of Gastroenterology, Chinese Medical Association. Chinese expert consensus of irritable bowel syndrome in 2020;Chin J Dig.,2020

5. Irritable bowel syndrome;Ford AC;Lancet.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases;Frontiers in Pharmacology;2023-12-20

2. Nocebo effects and influencing factors in the randomized clinical trials of chronic constipation: A systematic review and meta‐analysis;Neurogastroenterology & Motility;2023-11-07

3. Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review;Pharmacology & Therapeutics;2023-05

4. Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo‐controlled trial (CAPTIVATE);Neurogastroenterology & Motility;2023-02-05